1-10 of 10
Earlier ESR1m Detection May Delay Endocrine Resistance in HR+/HER2- Advanced Breast Cancer
Innovations In MedicineEarlier ESR1m Detection May Delay Endocrine Resistance in HR+/HER2- Advanced Breast Cancer
Putting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
Innovations In MedicinePutting Into Practice: ctDNA Monitoring of ESR1 Mutations During 1L HR+/HER2− Advanced Breast Cancer
ReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Medical Industry FeatureReDiscover-2: Currently Enrolling Patients With PIK3CA-Mutated Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP
Sarah Sammons, MD
Improving Preterm Birth Outcomes with Virtual Cervix Technology
Medical Industry FeatureImproving Preterm Birth Outcomes with Virtual Cervix Technology
Mirella Mourad, M.D.
Research Uncovers a Potential Biomarker for Postpartum Depression Risk
Medical Industry FeatureResearch Uncovers a Potential Biomarker for Postpartum Depression Risk
Lauren Osborne, M.D.
Freeze-All Policy: Is It Right for Everyone?
Global Women's Health AcademyFreeze-All Policy: Is It Right for Everyone?
Matheus Roque, M.D.
- advertisement
What is the POSEIDON Classification?
Global Women's Health AcademyWhat is the POSEIDON Classification?
Peter Humaidan, MD
Nikolaos P. Polyzos, MD
Impact of COS: Gonadotropics and Ovulation Trigger on Oocyte Competence
Global Women's Health AcademyImpact of COS: Gonadotropics and Ovulation Trigger on Oocyte Competence
Peter Humaidan, MD
LH vs hCG: Formulations and Physiological Differences
Global Women's Health AcademyLH vs hCG: Formulations and Physiological Differences
Sandro Esteves, MD, PhD
- advertisement
